Amyloidosis and Heart Failure with preserved ejection fraction, a more commom association than current epidemiological descriptions: Case Report

Detalhes bibliográficos
Autor(a) principal: Oliveira Potratz, Mateus
Data de Publicação: 2021
Outros Autores: Guimarães Araújo, Caio, Silva Moreira da Fraga, Rebeca, Costa Sylvestre, Rodolfo, Araújo Calil, Osmar
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Científica da Faculdade de Medicina de Campos
Texto Completo: https://www.fmc.br/ojs/index.php/RCFMC/article/view/555
Resumo: Amyloidosis is a disease characterized by the deposition of amyloid fibrils. When deposited in the heart, they can cause conduction disturbance, restrictive cardiomyopathy, diastolic dysfunction, low output and preserved ejection fraction heart failure (HFpEF), mainly related to transthyretin (TTR). Case description: A 70-year-old man, hypertensive, diabetic and dyslipidemic sought a cardiologist complaining of dyspnea on mild exertion, hyporexia, adynamia and edema in the lower limbs, with jugular turgescence at 45º and second heart sound hyperphonesis on cardiac auscultation. Complementary workup started to better elucidate the etiology of heart failure with electrocardiogram at rest showing low voltage, type B natriuretic peptide in the value of 3920 pg/ml, echocardiogram with biatrial enlargement, concentric hypertrophy of the left ventricle, global systolic function of the left ventricle preserved with an ejection fraction of 65%, hypertrophic septum and a heterogeneous and hyperrefringent infiltrative appearance. Due to the suspicion of amyloidosis, an investigation was carried out with cardiac magnetic resonance, which demonstrated late subendocardial enhancement characteristic of the pathology, and later a genetic test for amyloidosis of familial origin associated with variants in the TTR gene, confirming the diagnosis. Conclusion: Cardiac amyloidosis is a condition described as rare, but with numerous underdiagnosed cases. Conditions previously attributed to normal aging are likely due to cardiac amyloid deposits, leading to HFpEF. The existence of less invasive diagnostic methods, especially with dissociation between echocardiogram and electrocardiogram, contribute to early diagnosis, treatment plan and improved prognosis, modifying the natural history of the disease, avoiding the deposition of fibrils in the tissues.
id FMC-0_f9e7419b75d5650840da63ea3a1e3e3e
oai_identifier_str oai:ojs.www.fmc.br:article/555
network_acronym_str FMC-0
network_name_str Revista Científica da Faculdade de Medicina de Campos
repository_id_str
spelling Amyloidosis and Heart Failure with preserved ejection fraction, a more commom association than current epidemiological descriptions: Case ReportAmiloidose e Insuficiência Cardíaca com fração de ejeção preservada, uma associação mais comum do que as descrições epidemiológicas atuais: Relato de CasoInsuficiência CardíacaAmiloidoseCardiomiopatia RestritivaCardiomyopathy, RestrictiveAmyloidosis is a disease characterized by the deposition of amyloid fibrils. When deposited in the heart, they can cause conduction disturbance, restrictive cardiomyopathy, diastolic dysfunction, low output and preserved ejection fraction heart failure (HFpEF), mainly related to transthyretin (TTR). Case description: A 70-year-old man, hypertensive, diabetic and dyslipidemic sought a cardiologist complaining of dyspnea on mild exertion, hyporexia, adynamia and edema in the lower limbs, with jugular turgescence at 45º and second heart sound hyperphonesis on cardiac auscultation. Complementary workup started to better elucidate the etiology of heart failure with electrocardiogram at rest showing low voltage, type B natriuretic peptide in the value of 3920 pg/ml, echocardiogram with biatrial enlargement, concentric hypertrophy of the left ventricle, global systolic function of the left ventricle preserved with an ejection fraction of 65%, hypertrophic septum and a heterogeneous and hyperrefringent infiltrative appearance. Due to the suspicion of amyloidosis, an investigation was carried out with cardiac magnetic resonance, which demonstrated late subendocardial enhancement characteristic of the pathology, and later a genetic test for amyloidosis of familial origin associated with variants in the TTR gene, confirming the diagnosis. Conclusion: Cardiac amyloidosis is a condition described as rare, but with numerous underdiagnosed cases. Conditions previously attributed to normal aging are likely due to cardiac amyloid deposits, leading to HFpEF. The existence of less invasive diagnostic methods, especially with dissociation between echocardiogram and electrocardiogram, contribute to early diagnosis, treatment plan and improved prognosis, modifying the natural history of the disease, avoiding the deposition of fibrils in the tissues.Introdução: A amiloidose é uma doença caracterizada pelo depósito de fibrilas amiloides. Ao se depositarem no coração podem ocasionar distúrbio da condução, cardiomiopatia restritiva, disfunção diastólica, baixo débito e insuficiência cardíaca de fração de ejeção preservada (ICFEP), principalmente relacionada a transtirretina (TTR). Descrição do caso: Homem de 70 anos, hipertenso, diabético e dislipidêmico procurou o cardiologista queixando-se de dispneia aos pequenos esforços, hiporexia, adinamia e edema em membros inferiores, com turgência jugular a 45º e hiperfonese de segunda bulha na ausculta cardíaca. Iniciada a propedêutica complementar para melhor elucidação da etiologia da insuficiência cardíaca com eletrocardiograma em repouso evidenciando baixa voltagem, peptídeo natriurético do tipo B no valor de 3920 pg/ml, ecocardiograma com aumento biatrial, hipertrofia concêntrica do ventrículo esquerdo, função sistólica global do ventrículo esquerdo preservada com fração de ejeção de 65%, septo hipertrófico e dee aspecto infiltrativo heterogêneo e hiperrefringente. Devido à suspeita de amiloidose foi realizada investigação com ressonância magnética cardíaca, que demonstrou realce tardio subendocárdio característico da patologia e posteriormente teste genético para amiloidose de origem familiar associada a variantes no gene da TTR, confirmando o diagnóstico. Conclusão: A amiloidose cardíaca é uma patologia descrita como rara, porém com inúmeros casos subdiagnosticados. Condições antes atribuídas ao envelhecimento normal provavelmente são decorrentes de depósito amiloide cardíaco, levando à ICFEP. A existência de métodos diagnósticos menos invasivos, principalmente com dissociação entre ecocardiograma e eletrocardiograma, corroboram para o diagnóstico precoce, plano de tratamento e melhora do prognóstico, modificando a história natural da doença, evitando a deposição de fibrilas nos tecidos.Faculdade de Medicina de Campos (FMC)2021-10-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.fmc.br/ojs/index.php/RCFMC/article/view/55510.29184/1980-7813.rcfmc.555.vol.16.n2.2021Scientific Journal of the Medical School of Campos; Vol. 16 No. 2 (2021); 43-48Revista Científica da Faculdade de Medicina de Campos; v. 16 n. 2 (2021); 43-481980-7813reponame:Revista Científica da Faculdade de Medicina de Camposinstname:Faculdade de Medicina de Campos (FMC)instacron:FMCporhttps://www.fmc.br/ojs/index.php/RCFMC/article/view/555/260Copyright (c) 2021 Revista Científica da Faculdade de Medicina de Camposhttps://creativecommons.org/licenses/by-sa/4.0info:eu-repo/semantics/openAccess Oliveira Potratz, MateusGuimarães Araújo, Caio Silva Moreira da Fraga, RebecaCosta Sylvestre, Rodolfo Araújo Calil, Osmar 2021-11-11T18:22:40Zoai:ojs.www.fmc.br:article/555Revistahttps://www.fmc.br/ojs/index.php/RCFMC/PRIhttps://www.fmc.br/ojs/index.php/RCFMC/oai||revista@fmc.br1980-78131980-7813opendoar:2021-11-11T18:22:40Revista Científica da Faculdade de Medicina de Campos - Faculdade de Medicina de Campos (FMC)false
dc.title.none.fl_str_mv Amyloidosis and Heart Failure with preserved ejection fraction, a more commom association than current epidemiological descriptions: Case Report
Amiloidose e Insuficiência Cardíaca com fração de ejeção preservada, uma associação mais comum do que as descrições epidemiológicas atuais: Relato de Caso
title Amyloidosis and Heart Failure with preserved ejection fraction, a more commom association than current epidemiological descriptions: Case Report
spellingShingle Amyloidosis and Heart Failure with preserved ejection fraction, a more commom association than current epidemiological descriptions: Case Report
Oliveira Potratz, Mateus
Insuficiência Cardíaca
Amiloidose
Cardiomiopatia Restritiva
Cardiomyopathy, Restrictive
title_short Amyloidosis and Heart Failure with preserved ejection fraction, a more commom association than current epidemiological descriptions: Case Report
title_full Amyloidosis and Heart Failure with preserved ejection fraction, a more commom association than current epidemiological descriptions: Case Report
title_fullStr Amyloidosis and Heart Failure with preserved ejection fraction, a more commom association than current epidemiological descriptions: Case Report
title_full_unstemmed Amyloidosis and Heart Failure with preserved ejection fraction, a more commom association than current epidemiological descriptions: Case Report
title_sort Amyloidosis and Heart Failure with preserved ejection fraction, a more commom association than current epidemiological descriptions: Case Report
author Oliveira Potratz, Mateus
author_facet Oliveira Potratz, Mateus
Guimarães Araújo, Caio
Silva Moreira da Fraga, Rebeca
Costa Sylvestre, Rodolfo
Araújo Calil, Osmar
author_role author
author2 Guimarães Araújo, Caio
Silva Moreira da Fraga, Rebeca
Costa Sylvestre, Rodolfo
Araújo Calil, Osmar
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Oliveira Potratz, Mateus
Guimarães Araújo, Caio
Silva Moreira da Fraga, Rebeca
Costa Sylvestre, Rodolfo
Araújo Calil, Osmar
dc.subject.por.fl_str_mv Insuficiência Cardíaca
Amiloidose
Cardiomiopatia Restritiva
Cardiomyopathy, Restrictive
topic Insuficiência Cardíaca
Amiloidose
Cardiomiopatia Restritiva
Cardiomyopathy, Restrictive
description Amyloidosis is a disease characterized by the deposition of amyloid fibrils. When deposited in the heart, they can cause conduction disturbance, restrictive cardiomyopathy, diastolic dysfunction, low output and preserved ejection fraction heart failure (HFpEF), mainly related to transthyretin (TTR). Case description: A 70-year-old man, hypertensive, diabetic and dyslipidemic sought a cardiologist complaining of dyspnea on mild exertion, hyporexia, adynamia and edema in the lower limbs, with jugular turgescence at 45º and second heart sound hyperphonesis on cardiac auscultation. Complementary workup started to better elucidate the etiology of heart failure with electrocardiogram at rest showing low voltage, type B natriuretic peptide in the value of 3920 pg/ml, echocardiogram with biatrial enlargement, concentric hypertrophy of the left ventricle, global systolic function of the left ventricle preserved with an ejection fraction of 65%, hypertrophic septum and a heterogeneous and hyperrefringent infiltrative appearance. Due to the suspicion of amyloidosis, an investigation was carried out with cardiac magnetic resonance, which demonstrated late subendocardial enhancement characteristic of the pathology, and later a genetic test for amyloidosis of familial origin associated with variants in the TTR gene, confirming the diagnosis. Conclusion: Cardiac amyloidosis is a condition described as rare, but with numerous underdiagnosed cases. Conditions previously attributed to normal aging are likely due to cardiac amyloid deposits, leading to HFpEF. The existence of less invasive diagnostic methods, especially with dissociation between echocardiogram and electrocardiogram, contribute to early diagnosis, treatment plan and improved prognosis, modifying the natural history of the disease, avoiding the deposition of fibrils in the tissues.
publishDate 2021
dc.date.none.fl_str_mv 2021-10-29
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.fmc.br/ojs/index.php/RCFMC/article/view/555
10.29184/1980-7813.rcfmc.555.vol.16.n2.2021
url https://www.fmc.br/ojs/index.php/RCFMC/article/view/555
identifier_str_mv 10.29184/1980-7813.rcfmc.555.vol.16.n2.2021
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.fmc.br/ojs/index.php/RCFMC/article/view/555/260
dc.rights.driver.fl_str_mv Copyright (c) 2021 Revista Científica da Faculdade de Medicina de Campos
https://creativecommons.org/licenses/by-sa/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Revista Científica da Faculdade de Medicina de Campos
https://creativecommons.org/licenses/by-sa/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Faculdade de Medicina de Campos (FMC)
publisher.none.fl_str_mv Faculdade de Medicina de Campos (FMC)
dc.source.none.fl_str_mv Scientific Journal of the Medical School of Campos; Vol. 16 No. 2 (2021); 43-48
Revista Científica da Faculdade de Medicina de Campos; v. 16 n. 2 (2021); 43-48
1980-7813
reponame:Revista Científica da Faculdade de Medicina de Campos
instname:Faculdade de Medicina de Campos (FMC)
instacron:FMC
instname_str Faculdade de Medicina de Campos (FMC)
instacron_str FMC
institution FMC
reponame_str Revista Científica da Faculdade de Medicina de Campos
collection Revista Científica da Faculdade de Medicina de Campos
repository.name.fl_str_mv Revista Científica da Faculdade de Medicina de Campos - Faculdade de Medicina de Campos (FMC)
repository.mail.fl_str_mv ||revista@fmc.br
_version_ 1798042302127538176